Metagenomi Inc (NASDAQ: MGX) kicked off on Friday, down -3.90% from the previous trading day, before settling in for the closing price of $1.54. Over the past 52 weeks, MGX has traded in a range of $1.53-$11.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2385.08% over the last five years. While this was happening, its average annual earnings per share was recorded -3.19%. With a float of $21.87 million, this company’s outstanding shares have now reached $37.42 million.
The firm has a total of 202 workers. Let’s measure their productivity. In terms of profitability, gross margin is 95.06%, operating margin of -170.0%, and the pretax margin is -159.81%.
Metagenomi Inc (MGX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Metagenomi Inc is 41.49%, while institutional ownership is 27.17%. The most recent insider transaction that took place on Mar 05 ’25, was worth 1,744. In this transaction an insider of this company sold 930 shares at a rate of $1.87, taking the stock ownership to the 9,467 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Chief Financial Officer sold 1,808 for $1.87, making the entire transaction worth $3,390. This insider now owns 59,684 shares in total.
Metagenomi Inc (MGX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.19% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Take a look at Metagenomi Inc’s (MGX) current performance indicators. Last quarter, stock had a quick ratio of 6.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.15 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Analysing the last 5-days average volume posted by the [Metagenomi Inc, MGX], we can find that recorded value of 0.48 million was lower than the volume posted last year of 0.94 million. As of the previous 9 days, the stock’s Stochastic %D was 3.95%. Additionally, its Average True Range was 0.14.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 0.58%, which indicates a significant decrease from 3.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.06% in the past 14 days, which was lower than the 156.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2528, while its 200-day Moving Average is $2.8825. Now, the first resistance to watch is $1.5267. This is followed by the second major resistance level at $1.5733. The third major resistance level sits at $1.6067. If the price goes on to break the first support level at $1.4467, it is likely to go to the next support level at $1.4133. Should the price break the second support level, the third support level stands at $1.3667.
Metagenomi Inc (NASDAQ: MGX) Key Stats
The company with the Market Capitalisation of 55.33 million has total of 37,383K Shares Outstanding. Its annual sales at the moment are 52,300 K in contrast with the sum of -78,060 K annual income. Company’s last quarter sales were recorded 9,610 K and last quarter income was -23,400 K.
